Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Current Taxes (2021 - 2025)

Indivior Pharmaceuticals (INDV) has 5 years of Current Taxes data on record, last reported at $2.0 million in Q4 2025.

  • For Q4 2025, Current Taxes fell 71.43% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $2.0 million, down 71.43%, while the annual FY2025 figure was $2.0 million, 71.43% down from the prior year.
  • Current Taxes reached $2.0 million in Q4 2025 per INDV's latest filing, down from $4.0 million in the prior quarter.
  • Across five years, Current Taxes topped out at $17.0 million in Q2 2025 and bottomed at $2.0 million in Q4 2025.
  • Average Current Taxes over 5 years is $8.2 million, with a median of $7.5 million recorded in 2021.
  • Peak YoY movement for Current Taxes: grew 28.57% in 2022, then crashed 71.43% in 2025.
  • A 5-year view of Current Taxes shows it stood at $7.0 million in 2021, then increased by 28.57% to $9.0 million in 2022, then decreased by 11.11% to $8.0 million in 2023, then decreased by 12.5% to $7.0 million in 2024, then plummeted by 71.43% to $2.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Taxes were $2.0 million in Q4 2025, $4.0 million in Q3 2025, and $17.0 million in Q2 2025.